National Healthcare Agreement: PI 02–Incidence of selected cancers, 2018
Identifying and definitional attributes
|Metadata item type:||Indicator|
|Indicator type:||Progress measure|
|Short name:||PI 02–Incidence of selected cancers, 2018|
|Registration status:||Health, Standard 30/01/2018|
Incidence of selected cancers of public health importance.
|Indicator set:||National Healthcare Agreement (2018) Health, Standard 30/01/2018|
|Outcome area:||Prevention Health, Standard 07/07/2010|
|Quality statement:||National Healthcare Agreement: PI 02-Incidence of selected cancers, 2018 QS Health, Standard 30/01/2018|
Collection and usage attributes
Rates directly age-standardised to the 2001 Australian population.
Analyses by state and territory, remoteness and Socio-Economic Indexes for Areas (SEIFA) Index of Relative Socio-Economic Disadvantage (IRSD) are based on the state or territory and Statistical Area Level 2 (SA2) of the person at the time of their diagnosis.
Rates that are considered unstable and should be interpreted with caution will be noted. Rates that are considered very unstable will not be published.
100,000 × (Numerator ÷ Denominator)
Calculated separately for each type of cancer.
For melanoma, bowel and lung cancer: Number of new cases in the reported year.
For cervical and breast cancer in females: Number of new cases in females in the reported year.
|Numerator data elements:|
For melanoma, bowel and lung cancer: Total population.
For cervical and breast cancer in females: Total female population.
|Denominator data elements:|
2013 (resupplied for updated New South Wales (NSW) data), 2014—Nationally (for each cancer type), by 2011 SEIFA IRSD deciles (not reported).
2013 (resupplied for updated NSW data), 2014—State and territory (for each cancer type).
2013 (resupplied for updated NSW data) (not reported), 2014—State and territory (for each cancer type), by remoteness (Australian Statistical Geography Standard (ASGS) Remoteness Structure).
2013 (resupplied for updated NSW data), 2014—State and territory (for each cancer type), by 2011 SEIFA IRSD quintiles (not reported).
2013 (resupplied for updated NSW data), 2014—State and territory (for each cancer type), by Indigenous status.
Some disaggregation may result in numbers too small for publication.
Disaggregation by SEIFA and remoteness data are subject to availability of suitable population data.
|Disaggregation data elements:|
Most recent data available for 2018 National Healthcare Agreement performance reporting: 2013 for NSW and 2014 for all other jurisdictions.
2013 data will be resupplied to include data for NSW, which were not available for the 2017 report.
NSW data for 2014 are not available.
|Unit of measure:||Episode|
Indicator conceptual framework
|Framework and dimensions:||Health conditions|
Data source attributes
National Healthcare Agreement
|Organisation responsible for providing data:|
Australian Institute of Health and Welfare
|Further data development / collection required:|
Specification: Final, the measure meets the intention of the indicator.
|Related metadata references:|
Supersedes National Healthcare Agreement: PI 02–Incidence of selected cancers, 2017 Health, Superseded 30/01/2018
See also National Healthcare Agreement: PI 24–Survival of people diagnosed with notifiable cancers, 2018 Health, Standard 30/01/2018